2019-12-20 ç¥æžå€§åŠ,åå€å±å€§åŠ
æŠèŠ
åå€å±å€§åŠå€§åŠé¢å»åŠç³»ç ç©¶ç§ã®åæ°£åŒæææ(ç¥æžå€§åŠå
端èåç ç©¶ç°ç¹åœææ)ãã®ã°ã«ãŒãã¯ãè³å
ã®å
ç«çްèã§ãããã¯ãã°ãªã¢(泚1)ãè¡æ¶²è³é¢é(泚2)ã®æ©èœãå¶åŸ¡ããããšãçºèŠãããã®ã¡ã«ããºã ãåããŠæããã«ããŸããã
è¡æ¶²è³é¢éã¯ãè³ç°å¢ãäœåŸªç°ç³»ã®ç°å¢ãšéé¢ããæ§é ã§ãè³å
å€ãžã®ç©è³ªã®è¡ãæ¥ãå¶éããããšã§è³å
ã®ç°å¢ãäžå®ã«ä¿ã€åãããããææçãèªå·±å
ç«çŸæ£ãªã©ã®å
šèº«æ§ã®ççã«ãããã®æ©èœã¯äœäžããããšãç¥ãããŠããŸããããããªãããå
šèº«æ§ã®ççã«ãã£ãŠè¡æ¶²è³é¢éã®æ©èœãã©ã®ããã«ç Žç¶»ããŠããã®ãããã®è©³çްãªçµéããã³ã¡ã«ããºã ã¯ãããŸã§æããã§ã¯ãããŸããã§ããã
ä»åã®ç ç©¶ã§ã¯ãçäœ2å
åé¡åŸ®é¡(泚3)ãçšããŠãçããããŠã¹ã«ãããŠãå
šèº«æ§ã®ççã«äŒŽã£ãŠè¡æ¶²è³é¢éã®æ©èœãç Žç¶»ããéçšã詳现ã«èгå¯ããŸããããã®çµæãè¡æ¶²è³é¢éã«å¯ŸããŠãã¯ãã°ãªã¢ã®äœçšã¯æéã®çµéã«ãã£ãŠä¿è·çãªãã®ããé害çãªãã®ãžå€åããè¡æ¶²è³é¢éæ©èœã®å¶åŸ¡ã«éèŠãªåœ¹å²ãæ
ãããšã瀺ãããŸããããŸãããã¯ãã°ãªã¢ã®æŽ»æ§åãæå¶ããããšã§è¡æ¶²è³é¢éã®æ©èœç°åžžãæ¹åããããšãšããã®ã¡ã«ããºã ã«ã€ããŠäžçã«å
é§ããŠæãããšãªããŸããã
è¿å¹ŽãããŒãã³ãœã³ç
ãã¢ã«ããã€ããŒåèªç¥çãçµ±å倱調çãªã©ã®ç²Ÿç¥ã»ç¥çµå€æ§çŸæ£ã«ãããŠè¡æ¶²è³é¢éæ©èœã®ç°åžžã瀺ãããŠãããããä»åŸããã¯ãã°ãªã¢ãä»ããè¡æ¶²è³é¢éã®æ©èœå¶åŸ¡ã¯ãããã®çŸæ£ã®äºé²æ³ã»æ²»çæ³ã«ã€ãªããå¯èœæ§ããããŸãã
æ¬ç ç©¶ã¯ãåå€å±å€§åŠå€§åŠé¢å»åŠç³»ç ç©¶ç§ã®æšå±±åè³ææãèªç¶ç§åŠç ç©¶æ©æ§ççåŠç ç©¶æã®éåæ·³äžææãèªæ²»å»ç§å€§åŠã®å€§é䌞圊ææããã¥ãŒãµãŠã¹ãŠã§ãŒã«ãºå€§åŠã®Andrew J Moorhouseå士ã®ååãåŸãŠè¡ããŸããã
ãã®ç ç©¶ææã¯ã什åå
幎12æ20æ¥ä»(æ¥æ¬æé19æ)ãè±ç§åŠèªãNature Communicationsãã«æ²èŒãããŸããã
æ¬ç ç©¶ã¯ãæéšç§åŠçãåºç€ç ç©¶(B)ãæ°åŠè¡é åç ç©¶(ç ç©¶é åææ¡å)ãã«ãã¹ã±ãŒã«ç²Ÿç¥ç
æ
ã®æ§æççè§£ãæ°åŠè¡é åç ç©¶(ç ç©¶é åææ¡å)ã¹ã¯ã©ãã&ãã«ãã«ããè³æ©èœã®åçå¶åŸ¡ãç§åŠæè¡æ¯èæ©æ§ã[ãªãããã€ãª] å
ã®ç¹æ§ã掻çšããçåœæ©èœã®æç©ºéå¶åŸ¡æè¡ã®éçºãšå¿çšããã®ãµããŒããåããŠè¡ãããŸããã
ãã€ã³ã
âãã¯ãã°ãªã¢ã¯ççã«ãã£ãŠè¡ç®¡ã®åšå²ã«éç©ããççã®æ©æã«ã¯è¡æ¶²è³é¢éã®æ©èœäœäžãæå¶ããããççã®åŸæã«ã¯æ©èœãäœäžãããäœçšãæã€ããšãæãããšãªã£ãã
âãã¯ãã°ãªã¢ã®æŽ»æ§åãæããããšã§ãè¡æ¶²è³é¢éã®æ©èœãæ¹åããè¡æ¶²è³é¢éã®æ©èœãå¶åŸ¡ããã¡ã«ããºã ãæãããšãªã£ãã
âä»åã®çºèŠã¯ãè¡æ¶²è³é¢éã®æ©èœãé害ãããŠããç¥çµå€æ§çŸæ£ã«å¯Ÿããæ²»çæ³ã«ç¹ããå¯èœæ§ãããã
1.èæ¯
ç§ãã¡ã®è³ã®äžã«ã¯ãç¥çµçްèã®ã¿ãªããã°ãªã¢çްèãšãã°ãããã¯ãã°ãªã¢ãã¢ã¹ãããµã€ããè³ã®è¡ç®¡ã圢äœãè¡ç®¡å
ç®çްèãªã©æ§ã
ãªçްèãååšããçžäºäœçšããããšã§è³ã®æ©èœãä¿ãããŠããŸããè³å
ã®è¡ç®¡ã¯ãè¡ç®¡å
ç®çްèãã¢ã¹ãããµã€ããªã©ããæãç«ã€è¡æ¶²è³é¢éãšåŒã°ããç¹æ®ãªä»çµã¿ãããŠãããå
šèº«ãå·¡ã埪ç°ç³»ãšäžæ¢ç¥çµç³»ã®ç°å¢ãéãŠãããªã¢ãšããŠæ©èœããŠããŸããéåžžãã®ããªã¢ã«ãã£ãŠè¡æ¶²äžã®æå®³ãªç©è³ªãè³ã«äŸµå
¥ããããšã¯ãããŸããããææçãèªå·±å
ç«çŸæ£ãªã©ã®æ
¢æ§çãªççã«ãã£ãŠããªã¢æ©èœãäœäžãããšãç¥çµã®æŽ»åã«åœ±é¿ãåãŒãããšããããŸããã¢ã«ããã€ããŒåèªç¥æ©èœé害ããããŒãã³ãœã³ç
ãå€çºæ§ç¡¬åçãªã©ã®æ§ã
ãªäžæ¢ç¥çµç³»ã®çŸæ£ã«ãããŠè¡æ¶²è³é¢éã®æ©èœäœäžãå ±åãããŠãããç
æ
ã®é²è¡ãšããªã¢ç Žç¶»ã®é¢ä¿ããã³ç Žç¶»ãèµ·ããã¡ã«ããºã ã«æ³šç®ãéãŸã£ãŠããŸãã
ç ç©¶ã°ã«ãŒãã¯ä»åã®ç ç©¶ã§ãå
šèº«æ§ã®ççã«ãã£ãŠè¡æ¶²è³é¢éã®ç Žç¶»ãåŒãèµ·ããããéçšã詳现ã«èгå¯ããè³å
ã®å
ç«çްèã§ãããã¯ãã°ãªã¢ãè¡æ¶²è³é¢éã®å¶åŸ¡ã«éèŠãªåœ¹å²ãæ
ãããšããããŠãã®å¶åŸ¡ã®ã¡ã«ããºã ãäžçã«å
é§ããŠæããã«ããŸãããããã«ãã¯ãã°ãªã¢ã®æŽ»æ§åãæå¶ããããšã§ãè¡æ¶²è³é¢éã®æ©èœç°åžžãæ¹åãããããšãè§£æããŸããã
2.ç ç©¶ææ
çããããŠã¹ã®è³ã芳å¯ããããšãã§ããçäœ2å
åé¡åŸ®é¡ãçšããŠãå
šèº«æ§ã®ççãèªå°ãããã¢ãã«ããŠã¹ã®ãã¯ãã°ãªã¢ãçµæ¥çã«åäžéšäœã芳å¯ãããã®åããšè¡ç®¡ã®ééæ§ã芳å¯ããããšã§ããã¯ãã°ãªã¢ã®è¡æ¶²è³é¢éãžã®åœ±é¿ã調ã¹ãŸããã
ã¯ããã«ççãæç¶ããŠããèªå·±å
ç«çŸæ£ã®ã¢ãã«ããŠã¹ã®è³ã芳å¯ãããšãããè¡ç®¡ã«å¯çãããã¯ãã°ãªã¢ãå€ãååšãããããççã«ãããã¯ãã°ãªã¢ãè¡ç®¡ã«éç©ããããšãããã«äŒŽã£ãŠè¡æ¶²è³é¢éã®ééæ§ãå€åããããšãããããŸããããŸããã¯ãã°ãªã¢ãé€å»ããããŠã¹ã«ãããŠã¯ãæ©æã«ã¯è¡æ¶²è³é¢éã®ééæ§ãå¢å ãããã®åŸã«ãããŠã¯ééæ§ãæå¶ãããŠããããšãããããŸããã
ãããã®è©³çްãªååã¡ã«ããºã ãæããã«ããããã«ç¶²çŸ
çã«éºäŒåãè§£æããæ©æã«ãããŠã¯çްèã®æ¥çã«éèŠãªååã§ããã¯ããŒãã£ã³5(CLDN5)(泚4)ããã¯ãã°ãªã¢ã«çºçŸããåŸæçžã«ãããŠã¯è²ªé£(泚5)ã«ããããååã§ããCD68ããã¯ãã°ãªã¢ã«çºçŸããããšãããããŸããã
ããã«ææ°ã®é»åé¡åŸ®é¡ãçšããŠãã¯ãã°ãªã¢ãšè¡ç®¡ã®åŸ®çްæ§é ã芳å¯ãããšã现èã®æ¥çã«éèŠãªååã§ããCLDN5ãçºçŸãããã¯ãã°ãªã¢ããè¡ç®¡å
ç®çްèã«å¯çããŠããããšãããããŸãããããã«ããããã¯ãã°ãªã¢ãèªããç ŽããããŒã¹ã®æ°ŽæŒããæããã·ãŒã«ã®ããã«åããŠããããšãæããã«ãªããŸããã
ããã«ããã¯ãã°ãªã¢ã¯è¡ç®¡å
ç®çްèããæŸåºãããã±ã¢ã«ã€ã³(泚6)ã§ããCCL5(泚7)ã«å¿çããŠè¡ç®¡ã«èªåŒããCLDN5ãçºçŸããŠããããšãæãããšãªããŸãããCCL5ãé»å®³ããããšã«ããããã¯ãã°ãªã¢ã®è¡ç®¡ãžã®éç©ãèµ·ããããçµæãšããŠè¡æ¶²ã®æŒåºãæ©ãŸãçŸè±¡ã芳å¯ãããŸããã
ãŸãããã¯ãã°ãªã¢ã¯è²ªé£ã«ããããååã§ããCD68ãçºçŸããè¡æ¶²è³é¢éãæ§æããã¢ã¹ãããµã€ããšãã现èã®çªèµ·ãäžéšè²ªé£ããŠããããšãçºèŠããŸãããã¢ã¹ãããµã€ãã®çªèµ·ã¯è¡æ¶²è³é¢éã®ç¶æã«éèŠã§ããããšãç¥ããããã®æ§é ã®ç Žç¶»ããã£ããã«æŒåºãåŒãèµ·ãããããšèããããŸãã
æåŸã«ããã¯ãã°ãªã¢ã®æŽ»æ§åãæå¶ããæçç©è³ªãšããŠç¥ãããããããµã€ã¯ãªã³ãããŠã¹ã«æäžãããšããããã¯ãã°ãªã¢ã®è¡ç®¡ãžã®éç©ãšåæã®è¡æ¶²è³é¢éã®ä¿è·ã«åœ±é¿ãåãŒãããšãªããæ
¢æ§æã®æŒåºæªåãæå¶ã§ããããšãæããã«ãªããŸããã
ãããã®çµæãããè³å
ã®å
ç«çްèã§ãããã¯ãã°ãªã¢ãå
šèº«æ§ã®ççã«äŒŽã£ãŠè¡ç®¡ã«éç©ããççã®æ®µéã«ãã£ãŠãè¡æ¶²è³é¢éã«ä¿è·çã«ãé害æ§ã«ãäœçšããããšãæããã«ãªããŸããããããŠãã®ã¡ã«ããºã ãšããŠããã¯ãã°ãªã¢ã«ããè¡ç®¡å
ç®çްèãšã®çŽæ¥ã®æ¥è§Šãã¢ã¹ãããµã€ãã®çªèµ·ã®è²ªé£ãèµ·ãã£ãŠããããšãåããŠæããã«ããŸããã
3.ä»åŸã®å±é
粟ç¥ã»ç¥çµçŸæ£ã«ãããŠãè¡æ¶²è³é¢éã®ç Žç¶»ãæ°å€ãå ±åãããŠããããã®ç Žç¶»ããç æ ãé²è¡ããããšã«ã€ããŠã¯åºãç ç©¶ãããŠããŸããè¡æ¶²ã®è³å ãžã®æŒåºã«ãã£ãŠãç¥çµçŽ°èæ»ãç¥çµæŽ»åã®ç°åžžãçããããšããããŸã§æããã«ãããŠããŸãããä»åã®ç ç©¶ã§ãå šèº«æ§ã®ççãæ ¢æ§åããéããã¯ãã°ãªã¢ã®éå°ãªæŽ»æ§åãå¶åŸ¡ããããšããè¡æ¶²è³é¢éã®ä¿è·ã«å¹æçã§ããããšã瀺ãããŸãããããã«ãã¯ãã°ãªã¢ã¯åã«æŒåºãæªåãããã ãã§ãªããççåæã®æŒåºã®æå¶ã«ãéèŠãªåœ¹å²ãæ ã£ãŠãããä¿è·çãªåŽé¢ãæã¡åãããŠããããšãæããã«ãªããŸãããæ¬ç ç©¶ã®ææã¯ãå šèº«æ§ã®ççãåå ãšãªãäžæ¢ç¥çµç³»ã®çŸæ£ã«ãããŠããã¯ãã°ãªã¢ãæšçãšããæ°ããäºé²æ³ã»æ²»çæ³ã®éçºã«è²¢ç®ããããšãæåŸ ãããŸãã
<åèå³>

å³1ããã¯ãã°ãªã¢ã®è¡ç®¡ãžã®éç©
å
šèº«æ§ã®ççã«ãã£ãŠè¡ç®¡å
ç®çްèããCCL5ãç£çããããã¯ãã°ãªã¢ãè¡ç®¡åšå²ãžãšç§»åããéç©ããããšãæããã«ãªã£ãã

å³2ãççã«ããè¡æ¶²è³é¢éã®çµæ¥çå€åãšãã¯ãã°ãªã¢ã®æ©èœ
ççã®æ®µéã«ãã£ãŠããã¯ãã°ãªã¢ã¯è¡æ¶²è³é¢éã«ä¿è·çã«ãé害æ§ã«ãäœçšããããšãæããã«ãªã£ãã
4.çšèªè§£èª¬
(泚1)ãã¯ãã°ãªã¢
ãã¯ãã°ãªã¢ã¯è³å
å¯äžã®å
ç«çްèã§ããããã®å Žãåãããšãã§ããªãç¥çµçްèã«å¯ŸããŠãçµç¹ã®æå·ãç
åäœã®äŸµå
¥ã«åå¿ããŠè³å
ãç§»åããããšãã§ãããç§»åããå
ã§ã¯ãæ»çްèã䟵å
¥ããç
åäœã现èå
ã«åã蟌ãããšã«ãã£ãŠé€å»ããåããç¥ãããŠãã(泚: è²ªé£ åç
§)ãè¿å¹Žã§ã¯ç¥çµåè·¯ã®åœ¢æã«å¯ŸããŠãéèŠãªåœ¹å²ãæ
ãããšãæããã«ããããã®å€æ§ãªæ©èœã«æ³šç®ãéãŸã£ãŠããã
(泚2)è¡æ¶²è³é¢é
è³ã®è¡ç®¡ã«ååšãããè³å
å€ãžã®ç©è³ªã®ééãå¶éããæ©æ§ãè³å
ã®ç°å¢ãäžå®ã«ä¿ã¡ãç
åäœãççæ§ç©è³ªã®äŸµå
¥ããè³ãå®ãåããããããã®æ§é ã¯ãè¡ç®¡ã圢äœãå
ç®çްèãšãè¡ç®¡ã®åšå²ãåãå²ãããªãµã€ããã¢ã¹ãããµã€ããªã©ã®çްèãéãŸã£ãŠæ§æãããŠãããè¡æ¶²è³é¢éã®æ©èœãäœäžãããšãè¡æ¶²äžã®æåãè³ãžãšæŒåºããç¥çµæŽ»åãä¹±ãããšãããã
(泚3)çäœ2å
åé¡åŸ®é¡
é«åºåã®ã¬ãŒã¶ãŒãå
æºãšããŠãçãããŸãŸããŠã¹ã®è³ã芳å¯ããããšãã§ããé¡åŸ®é¡ãæ¬ç ç©¶ã§ã¯ã芳å¯å¯Ÿè±¡ã®çްèã«ç·è²èå
ã¿ã³ãã¯è³ª(GFP)ãçºçŸããéºäŒåæ¹å€ããŠã¹ãçšããèå
è²çŽ ã®æäžã«ããè¡æ¶²ãå¯èŠåããããšã§ã现èã®åããè¡æ¶²ã®æŒåºãåæã«èгå¯ããããšãã§ããã
(泚4)ã¯ããŒãã£ã³5(CLDN5)
è¡æ¶²è³é¢éã®åœ¢æã«éèŠãªãå¯ççµåã«é¢ããååã®ã²ãšã€ãè³å
ã§ã¯éåžžãè¡ç®¡å
ç®çްèãCLDN5ãçºçŸããŠããã现èå士ãå¯çããŠééãªãè¡ç®¡ã圢æããããšã§ãè¡ç®¡å
å€ãžã®ç©è³ªã®ç§»åãå¶éããã
(泚5)貪é£
æ»çްèã®ç Žçã倿¥ã®ç
åäœãªã©ã现èå
ã«åã蟌ã¿ãåè§£ããæ©èœãè³å
ã®ç°ç©ãé€å»ããä»çµã¿ãšããŠãè³å
ã®ç°å¢ãäžå®ã«ä¿ã€äžã§éèŠãªåœ¹å²ãæ
ãåããšããŠç¥ãããŠããã
(泚6)ã±ã¢ã«ã€ã³
ã±ã¢ã«ã€ã³ (Chemokine) ã¯ããµã€ãã«ã€ã³ã®äžçš®ã§ãããçœè¡çãªã©ã®éèµ°ãåŒãèµ·ããççã®åœ¢æã«é¢äžãããèµ°åæ§ã®(chemotactic)ãµã€ãã«ã€ã³(cytokine)ãæå³ããã
(泚7)CCL5
å
ç«çްèãççéšäœã«éããåããæã€éèµ°å åã®ã²ãšã€ã粟ç¥çç¶ã䌎ãèªå·±å
ç«çŸæ£ã«ãããŠãè³å
ããæ€åºãããããšãç¥ãããŠããŸããããè³ã«ããããã®åœ¹å²ã®è©³çްã¯ããã£ãŠããŸããã
5.çºè¡šéèª
æ²èŒçŽ:Nature Communications
è«æå:Dual Microglia Effects on Blood Brain Barrier Permeability Induced by Systemic Inflammation
èè
:Koichiro Haruwaka1,2,3, Ako Ikegami1, Yoshihisa Tachibana1, Nobuhiko Ohno4,5, Hiroyuki Konishi6, Akari Hashimoto1, Mami Matsumoto7,8, Daisuke Kato1,9, Riho Ono1, Hiroshi Kiyama6, Andrew J Moorhouse10, Junichi Nabekura2,3 and Hiroaki Wake1,9,11,12*
æå±:1. Division of System Neuroscience, Kobe University Graduate School of Medicine, Kobe, Japan
2. Division of Homeostatic Development, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan
3. Department of Physiological Sciences, The Graduate School for Advanced Study, Hayama, Japan
4. Department of Anatomy, Division of Histology and Cell Biology, Jichi Medical University, Tochigi, Japan
5. Division of Ultrastructural Research, National Institute for Physiological Sciences, Okazaki, Japan
6. Department of Functional Anatomy and Neuroscience, Nagoya University Graduate School of Medicine, Nagoya, Japan
7. Section of Electron Microscopy, Supportive Center for Brain Research, National Institute for Physiological Sciences, Okazaki, Japan
8. Department of Developmental and Regenerative Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
9. Department of Anatomy and Molecular Cell Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan
10. School of Medical Sciences, The University of New South Wales, Sydney, Australia
11. Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, Japan
12. Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama, Japan.
DOI:10.1038/s41467-019-13812-z
åãåããå
<ç ç©¶ã«ã€ããŠ>
åå€å±å€§åŠå»åŠéšã»å»åŠç³»ç ç©¶ç§
åå现èåŠãææãåæ°£ãåŒæ
<åºå ±æ
åœ>
åå€å±å€§åŠå»åŠéšã»å»åŠç³»ç ç©¶ç§ç·å課ç·åä¿

